Progress on the Path to Improving Outcomes in the Treatment of SCLC: Making the Most of Current Standard-of-Care Therapies and Exploring New Promising Research
Progress on the Path to Improving Outcomes in the Treatment of SCLC: Making the Most of Current Standard-of-Care Therapies and Exploring New Promising Research is organized by PVI, PeerView Institute for Medical Education.
Activity Release Date: June 5, 2023
Activity Expiration Date: July 4, 2024
Activity Description:
Important advances have occurred in the treatment of small cell lung cancer (SCLC) in recent years, and more exciting progress in the form of improved understanding of the disease biology, subtypes, and novel therapies is on the horizon. This educational activity, based on a recent live symposium produced in collaboration with LUNGevity Foundation, offers useful guidance for navigating the evidence supporting the use of current and emerging therapies in SCLC and translating the latest science to everyday clinical practice.
Educational Objectives:
Upon completion of this activity, participants should be better able to:
• Discuss the rationale, current or emerging clinical roles, and evidence supporting the use of the latest therapies for SCLC
• Integrate the current standard-of-care therapies into individualized treatment plans of eligible patients with SCLC based on the latest evidence, guideline recommendations, and patient needs/preferences
• Recommend enrollment in clinical trials evaluating current and new/emerging therapies to eligible patients with SCLC.